2018 News

• 12.25.2018
  Information

  Corporate Social Responsibility (CSR) page on our website has been updated

• 11.27.2018
  Press Release IR News

  Santen and Ube Industries Announce Launch of Glaucoma and Ocular Hypertension Treatment EYBELIS Ophthalmic Solution 0.002% in Japan

• 11.07.2018
  Press Release IR News

  Santen Reports the 2nd Quarter Fiscal 2018 Consolidated Performance

• 10.23.2018
  Information

  Corporate Social Responsibility (CSR) page on our website has been updated

• 09.25.2018
  Press Release IR News

  Santen Announces Drug Discovery and Development Agreement with PeptiDream

• 09.25.2018
  Press Release IR News

  Santen Donates to the 2018 Hokkaido Eastern Iburi Earthquake Relief Efforts in Japan

• 09.21.2018
  Press Release IR News

  Santen and Ube Industries Announce Receipt of Manufacturing and Marketing Approval for Glaucoma and Ocular Hypertension Treatment EYBELIS in Japan

• 09.21.2018
  Press Release IR News

  Santen Files for Manufacturing and Marketing Approval of Anti-Allergy Ophthalmic Drug Candidate DE-114A (JAN: Epinastine Hydrochloride)

• 09.13.2018
  Press Release IR News

  Personnel Changes of Corporate Officer

• 09.12.2018
  Press Release IR News

  Personnel Changes of Representative Director of the Board

• 08.01.2018
  Press Release IR News

  Santen Reports the 1st Quarter Fiscal 2018 Consolidated Performance

• 07.26.2018
  Press Release IR News

  Notice on Completion of Payment for Issuance of New Shares Under Restricted Stock-linked Remuneration Program

• 07.17.2018
  Press Release IR News

  Santen Donates to Japan Flood and Landslide Relief Efforts

• 07.10.2018
  Press Release IR News

  Santen Receives Marketing Authorisation from the European Commission for DE-076C (Verkazia) as an Orphan Medicinal Product

• 06.28.2018
  Information

  Corporate Social Responsibility (CSR) page on our website has been updated

• 06.26.2018
  Press Release IR News

  Notice on the Issuance of New Shares Under Restricted Stock-Linked Remuneration Program

• 06.04.2018
  Press Release IR News

  Santen Announces Medium-Term Plan (MTP2020)

• 05.09.2018
  Press Release IR News

  Notice on the Introduction of a New Stock-Linked Remuneration Program and Change to Director Remuneration

• 05.09.2018
  Press Release IR News

  Notice of Board of Director and Corporate Auditor Nominations

• 05.09.2018
  Press Release IR News

  Santen Reports Fiscal 2017 Consolidated Performance

• 03.29.2018
  Information

  CSR page on our website has been updated

• 03.14.2018
  Press Release IR News

  Notice of Corporate Officer Appointments

• 02.23.2018
  Press Release

  Santen to Conduct a Public Awareness Campaign for Glaucoma During World Glaucoma Week March 11 - 17

• 02.20.2018
  Information

  Santen Awarded for Corporate Governance

• 02.20.2018
  Press Release IR News

  Santen Announces Appointment of New President

• 02.06.2018
  Press Release IR News

  Santen Reports the 3rd Quarter Fiscal 2017 Consolidated Performance

News Archive